A Comparative Study of Pravastatin vs Placebo as Primary Prevention of Severe Subcutaneous Breast Fibrosis in Hyper-radiosensitive Identified Patients With Breast Cancer

NCT04385433 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

15

Enrollment

OTHER

Sponsor class

Stopped Not enough patients enrolled

Conditions

Breast Cancer

Interventions

DRUG: EXPERIMENTAL ARM
OTHER: CONTROL GROUP
RADIATION: Standard adjuvant whole breast radiotherapy (50Gy/ 25 fractions to whole breast) followed or not by a boost to tumor bed (16Gy/ 8 fractions)

Sponsor

Institut du Cancer de Montpellier - Val d'Aurelle